Вопросы вирусологии, 2021 Introduction. Rubella virus has pronounced teratogenic properties that can cause generalized and persistent intrauterine infection of the fetus. As a result, the control of the loss of teratogenicity inherent in «wild-type» virus strains is a necessary ...
I. N. Lavrentjeva +4 more
doaj +1 more source
Vaccine-associated Rubella – a report of two cases and a review of the literature
Human Vaccines & Immunotherapeutics, 2021 We report the clinical characteristics of two adult patients, presenting with a typical erythematous rash consistent with rubella disease after MMR vaccination. Both patients had an uncomplicated clinical course and recovered uneventfully.
Sean Wei Xiang Ong +9 more
doaj +1 more source
Balancing evidence and uncertainty when considering rubella vaccine introduction. [PDF]
PLoS ONE, 2013 BACKGROUND:Despite a safe and effective vaccine, rubella vaccination programs with inadequate coverage can raise the average age of rubella infection; thereby increasing rubella cases among pregnant women and the resulting congenital rubella syndrome ...
Justin Lessler, C Jessica E Metcalf
doaj +1 more source
Changes in the Epidemiology of Rubella: The Influence of Vaccine-Introducing Methods and COVID-19
Vaccines, 2023 Rubella is an infectious disease caused by the rubella virus. Congenital rubella syndrome is a risk for all newborns if pregnant women are infected with rubella, raising an important public health issue.
Naruhito Otani +6 more
doaj +1 more source
The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015
Vaccines, 2022 Mumps and rubella are vaccine-preventable viral diseases through the measles-mumps-rubella-varicella (MMRV) vaccine, administered at 12 months and again at 6 years.
Ravit Bassal +12 more
doaj +1 more source
Biological view of vaccination described by mathematical modellings: from rubella to dengue vaccines
Mathematical Biosciences and Engineering, 2019 The only rubella vaccine available in North America is the RA27/3 strain (isolated from the kidney of a rubella-infected fetus and attenuated) licensed in 1979, which substituted HPV77/DE5 strain vaccine due to concerns about waning immunity.
Hyun Mo Yang +1 more
doaj +1 more source
Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal [PDF]
, 2018 Although most countries in the WHO European Region were verified in 2017 as having interrupted endemic measles transmission, nine countries were still endemic. Among these, Italy accounted for the second highest number of measles cases reported in Europe
Adamo, Giovanna +9 more
core +2 more sources
Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models [PDF]
, 2009 We evaluated the effectiveness of a measles vaccine campaign in rural Kenya, based on oral-fluid surveys and mixture-modelling analysis. Specimens were collected from 886 children aged 9 months to 14 years pre-campaign and from a comparison sample of 598
A. BETT +13 more
core +2 more sources
Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda
BMC Infectious Diseases, 2020 Background Control of Rubella and Congenital Rubella Syndrome using vaccination has shown great success in the America’s. Uganda is due to introduce the Rubella vaccine however the magnitude of transmission is not well documented.
Fred Bagenda +4 more
doaj +1 more source
Mandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric society. [PDF]
, 2018 BACKGROUND: High rates of vaccination coverage are important in preventing infectious diseases. Enforcing mandatory vaccinations is one of the strategies that some Countries adopted to protect the community when vaccination coverage is not satisfactory ...
Bozzola E +5 more
core +2 more sources